OneMedNet Corp (ONMDW) Financial Statements (2025 and earlier)

Company Profile

Business Address TRIDENT COURT, 1 OAKCROFT ROAD
SURREY, KT9 1BD
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1441721,93440717447
Cash and cash equivalent1441721,93440717447
Restricted cash and investments    300  
Receivables2472136375253152
Other undisclosed current assets1,2403,2342,307174229166
Total current assets:1,6313,6194,304956656365
Noncurrent Assets
Property, plant and equipment10110884859499
Total noncurrent assets:10110884859499
TOTAL ASSETS:1,7323,7274,3881,041750464
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:6,8706,3716,1616,4775,8754,682
Accrued liabilities78655238  
Other undisclosed accounts payable and accrued liabilities6,7926,3066,1096,4395,8754,682
Deferred revenue503561428519456254
Debt6,9257,0456,8913,2702,6171,637
Other liabilities  283   283
Other undisclosed current liabilities 3,8564,9685,1489,7805,7106,517
Total current liabilities:18,15419,22818,62820,04614,65813,373
Noncurrent Liabilities
Long-term debt and lease obligation     754465
Long-term debt, excluding current maturities     754465
Liabilities, other than long-term debt12844928221668
Other liabilities12844928221668
Other undisclosed noncurrent liabilities    1601,023 
Total noncurrent liabilities:128449281821,793533
Total liabilities:18,28219,67718,65620,22816,45113,906
Temporary equity, including noncontrolling interest      
Equity
Equity, attributable to parent(16,550)(15,950)(14,268)(19,187)(15,701)(13,442)
Common stock222222
Treasury stock, value(529)(529)(529)(529)(529) 
Additional paid in capital87,44886,14685,45578,47878,37577,996
Accumulated deficit(103,471)(101,569)(99,196)(97,138)(93,549)(91,440)
Other undisclosed equity      
Total equity:(16,550)(15,950)(14,268)(19,187)(15,701)(13,442)
TOTAL LIABILITIES AND EQUITY:1,7323,7274,3881,041750464

Income Statement (P&L) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Revenues137261422272481,021
Gain on disposition of assets for financial service operations531     
Cost of revenue(361)(52)(226)(329)(317) 
Gross profit:(224)(26)(84)(102)(69) 
Operating expenses(2,000)(2,640)(2,303)(2,352)(2,032)(5,269)
Other undisclosed operating loss      (27)
Operating loss:(2,224)(2,666)(2,387)(2,454)(2,101)(5,295)
Nonoperating income (expense)322294329(1,135)(8) 
Investment income, nonoperating   160   
Other nonoperating income (expense) (8)(4)(20)7 
Interest and debt expense(31) (36)(41)15 
Other undisclosed loss from continuing operations before equity method investments, income taxes      (26,920)
Income (loss) from continuing operations before equity method investments, income taxes:(1,933)(2,372)(2,094)(3,630)(2,094)(32,215)
Other undisclosed loss from continuing operations before income taxes  (15)   (849)
Income (loss) from continuing operations before income taxes:(1,933)(2,387)(2,094)(3,630)(2,094)(33,064)
Income tax benefit      192
Other undisclosed loss from continuing operations  (2)    
Net income (loss):(1,933)(2,389)(2,094)(3,630)(2,094)(32,872)
Other undisclosed net income (loss) attributable to parent31153641(15) 
Net income (loss) attributable to parent:(1,902)(2,374)(2,058)(3,589)(2,109)(32,872)
Undistributed earnings (loss) allocated to participating securities, basic      
Other undisclosed net loss available to common stockholders, basic      
Net income (loss) available to common stockholders, basic:(1,902)(2,374)(2,058)(3,589)(2,109)(32,872)
Dilutive securities, effect on basic earnings per share      
Other undisclosed net loss available to common stockholders, diluted      
Net income (loss) available to common stockholders, diluted:(1,902)(2,374)(2,058)(3,589)(2,109)(32,872)

Comprehensive Income ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Net income (loss):(1,933)(2,389)(2,094)(3,630)(2,094)(32,872)
Comprehensive income (loss), net of tax, attributable to parent:(1,933)(2,389)(2,094)(3,630)(2,094)(32,872)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: